T1	Participants 42 67	in human breast carcinoma
T2	Participants 1026 1033	(Ki67).
T3	Participants 1034 1150	Eighty-two postmenopausal invasive ductal carcinoma patients were enrolled in CAAN study from November 2001 to April
